50% of patients (3/6) with baseline HBsAg <1000 IU/mL achieved a functional cure (defined as sustained HBsAg loss and HBV DNA less than the lower limit of quantification (LLOQ) 24 weeks off all ...
At an event hosted by BioPharma Dive, drugmaker executives and investors discussed the importance of focus, smart spending ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback